A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Condition(s):Neuroendocrine NeoplasmLast Updated:April 30, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Neuroendocrine NeoplasmLast Updated:April 30, 2018Unknown status
Condition(s):Pancreatic Neuroendocrine Tumor G2Last Updated:October 18, 2023Completed
Condition(s):Breast Cancer; LymphoceleLast Updated:July 28, 2022Terminated
Condition(s):Autosomal Dominant Polycystic KidneyLast Updated:March 15, 2024Recruiting
Condition(s):Neuroendocrine TumorLast Updated:March 1, 2023Recruiting
Condition(s):Liver Transplantation; Renal FailureLast Updated:May 3, 2023Active, not recruiting
Condition(s):Major Liver ResectionLast Updated:February 14, 2024Terminated
Condition(s):Colonic Motility Index; ConstipationLast Updated:December 21, 2015Completed
Condition(s):HealthyLast Updated:April 22, 2022Completed
Condition(s):Octreotide; SputumLast Updated:October 8, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.